All | Profiles | p Value | ||||
---|---|---|---|---|---|---|
A (12%) | B (36%) | C (34%) | D (17%) | |||
Age (months) | ||||||
<2 | 28 | 7 | 20 | 37 | 45 | <0.001 |
2–5.9 | 35 | 22 | 41 | 36 | 30 | |
6–11.9 | 22 | 41 | 24 | 18 | 15 | |
≥12 | 14 | 30 | 15 | 9 | 10 | |
Girls | 41 | 33 | 41 | 40 | 45 | 0.01 |
Race | ||||||
White | 61 | 57 | 60 | 61 | 69 | <0.001 |
Black/African-American | 24 | 32 | 25 | 23 | 21 | |
Other | 14 | 11 | 15 | 16 | 10 | |
Hispanic ethnicity | 36 | 32 | 38 | 34 | 40 | 0.07 |
Parental history of asthma | 31 | 37 | 32 | 31 | 27 | 0.08 |
ED presentation | ||||||
Fever | 29 | 23 | 30 | 32 | 27 | 0.05 |
Apnoea | 7 | 6 | 4 | 10 | 10 | <0.001 |
Inadequate oral intake | 50 | 38 | 46 | 60 | 45 | <0.001 |
ICU and intubation/CPAP | ||||||
No ICU | 82 | 86 | 94 | 64 | 88 | <0.001 |
ICU without intubation/CPAP | 11 | 11 | 5 | 18 | 8 | |
ICU with intubation/CPAP | 7 | 3 | 1 | 17 | 4 | |
Viral aetiology | ||||||
RSV only | 49 | 0 | 65 | 52 | 46 | <0.001 |
Rhinovirus only | 8 | 38 | 0 | 3 | 10 | |
RSV and rhinovirus | 13 | 8 | 10 | 20 | 9 | |
RSV and other non-rhinovirus | 10 | 0 | 15 | 10 | 6 | |
Rhinovirus and other non-RSV | 5 | 27 | 0 | 2 | 5 | |
Non-RSV and non-rhinovirus | 15 | 28 | 9 | 13 | 24 | |
Number of pathogens | ||||||
No pathogen identified | 6 | 10 | 4 | 6 | 10 | <0.001 |
1 | 64 | 53 | 71 | 61 | 65 | |
2 | 24 | 29 | 22 | 27 | 20 | |
≥3 | 5 | 8 | 4 | 6 | 4 |
Results presented as %.
Profile A: history of wheezing/eczema, wheezing at ED presentation, more often rhinovirus. Profile B: wheezing at ED presentation, more often RSV only. Profile C: most severe. Profile D: non-wheezing at ED presentation, least severe.
CPAP, continuous positive airway pressure; ED, emergency department; ICU, intensive care unit; LCA, latent class analysis; RSV, respiratory syncytial virus.